CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to reduce dangerous side effect in blood cancer patients
Disease control OngoingThis early-phase study tests whether giving rituximab and high-dose steroids before venetoclax can safely lower the number of cancer cells in people with relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to reduce the risk of tumor lysis…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New combo aims to control blood cancer without lifelong treatment
Disease control OngoingThis study tests whether a combination of acalabrutinib and venetoclax can control chronic lymphocytic leukemia or small lymphocytic lymphoma as well as the standard venetoclax plus obinutuzumab regimen. About 607 adults who have not yet been treated for their disease will receiv…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 14, 2026 12:02 UTC